Covid-19 – Day 135: Johnson & Johnson Vaccine against the SARS-CoV-2


(E) Johnson & Johnson has just announced, that in partnership with the US federal government, it will invest more than $1 billion in a potential vaccine, developed at the Beth Israel Deaconess Medical Center led by Professor Dan Barouch, against the SARS-CoV-2.

The clinical trials, for that vaccine, are planned to start by September, and if there are successful, the vaccine could be ready for emergency use early next year.

For more…

A video from NBC Boston on Professor Barouch’s research:

Johnson & Johnson’s press release:

An article on the Johnson & Johnson’s announcement from the Boston Globe:

Note: The picture above is a view of Boston downtown.

Copyright © 2005-2020 by Serge-Paul Carrasco. All rights reserved.
Contact Us: asvinsider at gmail dot com

Categories: Biology, Coronavirus